|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Net realized losses (gains) on investments | |||||
| Net losses (gains) on funds withheld reinsurance treaties | |||||
| Mortality, expense and surrender charges | |||||
| Amortization of discount and premium on investments | |||||
| Share-based compensation | |||||
| Change in: | |||||
| Accrued investment income | |||||
| Future policy benefits | |||||
| Cash flows from investing activities: | |||||
| Sales, maturities and repayments of: | |||||
| Debt securities | |||||
| Equity securities | |||||
| Mortgage loans | |||||
| Purchases of: | |||||
| Debt securities | |||||
| Equity securities | |||||
| Mortgage loans | |||||
| Settlements related to derivatives and collateral on investments | |||||
| Other investing activities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Policyholders' account balances: | |||||
| Deposits | |||||
| Withdrawals | |||||
| Net transfers from (to) separate accounts | |||||
| Proceeds from (payments on) repurchase agreements and securities lending | |||||
| Net proceeds from (payments on) Federal Home Loan Bank notes | |||||
| Proceeds from debt | |||||
| Settlements related to deferred premium on derivatives | |||||
| Payments on debt | |||||
| Debt issuance costs | |||||
| Issuance of debt of consolidated investment entities | |||||
| Repayments of debt of consolidated investment entities | |||||
| Contributions from partners of consolidated investments | |||||
| Distributions from partners of consolidated investments | |||||
| Disposition of shares held in trust at cost, net | |||||
| Dividends on common stock | |||||
| Dividends on preferred stock | |||||
| Purchase of treasury stock | |||||
| Issuance of preferred stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Total cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental cash flow information | |||||
| Income taxes paid (received) | |||||
| Interest paid | |||||
| Non-cash investing activities | |||||
| Debt securities acquired from exchanges, payments-in-kind, and similar transactions | |||||
| Other invested assets acquired from stock splits and stock distributions | |||||
| Non-cash financing activities | |||||
| Non-cash dividend equivalents on stock based awards | |||||
| Reconciliation to Consolidated Balance Sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash (included in Other assets) | |||||
Loading...